Last week, Slack Capital - an Australian investment research publication - released an investment report on eXoZymes accompanied by multiple interviews with our management team. This is the last of four interviews and is with the Chairman of our Board of Directors, Chris Marlett from MDB Capital. The interview focuses on MDB's process of selecting high-tech companies to take public, as well as Marlett's take on the potential of eXoZymes.

Full interview is available here:

https://exozymes.com/blog/slack-capital-chairman

#AI #biomanufacturing #nutraceuticals #enzymes #exozymes #investmentreport